Voxelotor: increased hemoglobin, reduced hemolysis markers in sickle cell disease
Voxelotor increased hemoglobin levels and reduced markers of hemolysis compared to placebo in patients with sickle cell disease, according to…
Discover the next-generation of MRD assessment
Discover the next-generation of MRD assessment. Gain insights into the science of molecular testing and its potential
Clinical Utilization of MRD in Multiple Myeloma: an in-depth view
The aim of this programme is to improve knowledge of the measurement, clinical application and interpretation of MRD in MM
ALAN leads the first global HRQoL survey in acute leukemia
Filling the information void: acute leukemia quality of life data is lacking and ALAN is calling for your support!
Watch webcast presentations from the ERIC 2018 International Meeting now!
Addressing the challenges in multiple myeloma
Advances continue to be made in the diagnosis and treatment of multiple myeloma, leading to improved patient care and outcomes….